This compound is primarily utilized in pharmaceutical research and development, particularly in the synthesis of active pharmaceutical ingredients (APIs). It serves as a key intermediate in the production of compounds targeting central nervous system disorders, such as anxiety and depression, due to its structural properties that interact with neurotransmitter systems. Additionally, it is explored in the design of drugs with potential analgesic or anti-inflammatory effects. Its fluorophenyl and pyran moieties make it a valuable building block for creating molecules with enhanced bioavailability and receptor specificity. Researchers also investigate its role in the development of novel therapeutic agents for neurological and psychiatric conditions.